Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
AXGN Stock — Axogen, Inc.
Axogen, Inc. (AXGN)
Updated October 16, 2026.
AXGN is a Stock. Total return is 958.9% over the past 39.8 years.
Axogen develops and commercializes medical technologies for peripheral nerve regeneration and repair, including processed nerve allografts, coaptation aids, and nerve protection products sold to hospitals and surgery centers worldwide. The company does not currently distribute dividends to shareholders. Axogen appeals primarily to growth-oriented investors seeking exposure to the medical device and surgical implant sectors rather than income-focused investors.
AXGN dividend yield and income
Price as of 2026-10-16.
The ex-dividend date is 01/27/2010. The payment date is 02/12/2010.
| Ex-date | As paid | Per current share | Change from previous payment |
|---|---|---|---|
| 2010-01-27 | $1 | $1 | 1566.7% Unclassified cash |
| 2005-02-23 | $0.06 | $0.06 | 37.0% Unclassified cash |
| 1992-07-10 | $0.0483 | $0.0438 | — |
| 1992 total | — | $0.0438 | — |
| 2005 total | — | $0.06 | 37.0% |
| 2010 total | — | $1 | 1566.7% |
AXGN performance
Price and return data through 2026-10-16.
Total return is 958.9% over the past 39.8 years. Over the past year its total return — price change plus distributions reinvested — is 106.8%. Its deepest 1-year drawdown was 33.1%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -23.8% | — |
| 3M | -13.0% | — |
| 6M | -7.4% | — |
| YTD | 5.8% | — |
| 1Y | 106.8% | — |
| 2Y CAGR | — | 54.80% |
| 3Y CAGR | — | 102.10% |
| 5Y CAGR | — | 20.50% |
| 10Y CAGR | — | 14.80% |
| Since inception (39.8 years) | 958.9% | 6.10% |
AXGN key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 12/17/1986
- Distribution frequency
- None
- Last close
- $34.62 (as of 2026-10-16)
- Market cap
- $2,031,207,780
- Average volume
- 1127465.0
- Ex-dividend date
- 01/27/2010
- Payment date
- 02/12/2010
- Beta
- 1.166
- Payout ratio
- 0.0%
- Forward P/E
- 102.0408
- EPS
- $-0.67
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
AXGN risks and drawbacks
The deepest 1-year drawdown on record here is 33.1%.
Who may consider AXGN — and who may not
It is a weaker fit for investors who need monthly cash flow (AXGN does not currently distribute). This is educational context, not a recommendation to buy or sell.
More on AXGN
Frequently asked questions
Does AXGN pay monthly?
No. AXGN does not currently distribute.
When does AXGN pay a dividend?
AXGN does not currently distribute. The ex-dividend date is 01/27/2010. The payment date is 02/12/2010.
How has AXGN performed?
Total return is 958.9% over the past 39.8 years. Over the past year its total return — price change plus distributions reinvested — is 106.8%. Its deepest 1-year drawdown was 33.1%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.